𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Management of coronary artery perforation in patients receiving abciximab

✍ Scribed by Carlos Del Campo; Robert Zelman

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
17 KB
Volume
54
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Successful treatment of coronary artery
Successful treatment of coronary artery perforation in an abciximab-treated patient by microcoil embolization
✍ Abid R. Assali; Ali Moustapha; Stefano Sdringola; Michael Rihner; Richard W. Sma πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

We describe a case of type 2 coronary artery perforation in a 73-year-old man undergoing coronary artery rotablation and stenting with abciximab therapy. The coronary artery perforation was successfully treated by coil embolization with Trufill pushable coils made from platinum alloy and synthetic f

A comparison of total hospital costs for
A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban
✍ Patrick L. McCollam; Maureen J. Lage; Mohan Bala πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 1 views

## Abstract The purpose of this study was to examine the total hospital costs associated with the receipt of abciximab versus tirofiban for percutaneous coronary intervention (PCI) patients. Hospital billing data for patients with a primary procedure of PCI was examined for the period of July 1998